Novo Nordisk’s Ozempic gains USFDA approves to cut risk of diabetic kidney disease progression
The approval was based on data from a late-stage study, which showed that Ozempic helped cut the risk of death from chronic kidney…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.